BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 23631604)

  • 1. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
    Moreno-Fernandez J; Gomez FJ; Gazquez M; Pedroche M; García-Manzanares A; Tenias JM; Benito P; Gomez IR
    Diabetes Technol Ther; 2013 Jul; 15(7):596-600. PubMed ID: 23631604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.
    Moreno-Fernandez J; Gómez FJ; Gálvez Moreno MÁ; Castaño JP
    J Diabetes Res; 2016; 2016():4171789. PubMed ID: 28004007
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
    Peyrot M; Rubin RR
    Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
    Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time continuous glucose monitoring improves glycemic control and reduces hypoglycemia: Real-world data.
    Kant R; Antony MA; Geurkink D; Gilreath N; Chandra L; Zipprer E; Munir KM; Chandra R; Parker VG; Verma V
    Prim Care Diabetes; 2022 Dec; 16(6):786-790. PubMed ID: 36117090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan.
    Lin CH; Huang CH; Tsai JS; Hsieh SH; Sun JH; Huang BY; Huang MJ; Huang YY
    Endocr J; 2011; 58(10):835-40. PubMed ID: 21828934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Adherence to Continuous Glucose Monitoring in the Management of Type 1 Diabetes Patients on Sensor-Augmented Pump Therapy: The SENLOCOR Study.
    Picard S; Hanaire H; Baillot-Rudoni S; Gilbert-Bonnemaison E; Not D; Reznik Y; Guerci B
    Diabetes Technol Ther; 2016 Mar; 18(3):127-35. PubMed ID: 26950530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life.
    Jenkins AJ; Krishnamurthy B; Best JD; Cameron FJ; Colman PG; Hamblin PS; O'Connell MA; Rodda C; Teede H; O'Neal DN
    Diabetes Technol Ther; 2011 Feb; 13(2):105-9. PubMed ID: 21284476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial.
    Jenkins AJ; Krishnamurthy B; Best JD; Cameron FJ; Colman PG; Farish S; Hamblin PS; O'Connell MA; Rodda C; Rowley K; Teede H; O'Neal DN
    Diabetes Care; 2010 Jun; 33(6):1242-8. PubMed ID: 20215457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
    Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
    Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.